Veeva Systems Inc.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
What does it do?
Veeva Systems builds software specifically for drug and biotech companies — think of it as Salesforce, but built exclusively for pharma. A sales rep at Pfizer uses Veeva to track which doctors they've visited and what was discussed. A regulatory team at a biotech startup uses Veeva to store and manage all the documents needed to get a drug approved by the FDA. Veeva is so deeply embedded in how life sciences companies operate that switching away from it is genuinely painful.
Veeva sits at the intersection of two durable trends: the global pharma industry spending more on technology, and the shift from on-premise software to cloud. With over 1,000 life sciences customers — including most of the world's largest drug companies — Veeva has built what investors call a 'moat,' meaning it's very hard for competitors to displace it. Right now, the company is also in the middle of a major product transition that could significantly expand how much revenue it earns per customer.
How does it make money?
Veeva makes money by charging life sciences companies a recurring subscription fee — customers pay annually to keep using its software, which makes revenue predictable. The business has two main segments: Commercial Cloud, which helps pharma sales and marketing teams manage relationships with doctors and healthcare providers, and Vault, which handles documents, clinical trials, and regulatory submissions. Revenue grew from $2.7B to $3.2B in the latest year, an increase of roughly 19%, and the company converted $0.9B of that into net profit, showing strong profitability.
Why do investors care?
The core growth story is Vault CRM — Veeva's bet-the-company move to replace its own legacy CRM product (built on Salesforce's platform) with a fully owned system. If customers successfully migrate to Vault CRM, Veeva stops paying Salesforce a cut and earns more per customer. Beyond that, Veeva is still underpenetrated in biotech and international markets, meaning there are more customers to win. For the thesis to work, the Vault CRM migration needs to go smoothly and customers need to keep expanding their use of Veeva's products over time.
Deep Dive
MemberA full investor briefing on Veeva Systems Inc. — history, leadership, risks, and outlook.